The House Appropriations Committee advanced a fiscal 2018 FDA funding bill to the floor Wednesday (July 12) by voice vote, maintaining $2.8 billion in discretionary funding for the agency and adding $60 million to implement the 21st Century Cures Act. Debate sparked over an amendment which would have allowed office-use compounding where authorized by state law, but it was withdrawn after Rep. Robert Aderholt (R-GA) promised to work on the issue in the future with Rep. Chris Stewart (R-UT). The...